Ono Venture Investment is the corporate venture capital arm of Ono Pharmaceutical Co.,Ltd. , an R&D-oriented pharmaceutical company succeeded in delivery of “First in class” medicines to patients such as OPDIVO® (nivolumab).
Focus Areas
Investment Types
Notable Investments
